Hospital
Pender Community Hospital District
Pender Community Hospital District was paid $626K by Medicaid between Jan 2018 and Mar 2024, across 36 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 15% of everything it billed.
33Billing provider infoPENDER COMMUNITY HOSPITAL DISTRICT
PENDER, NE 68047
PENDER, NE 68047
33aNPI1578627196assigned 12/20/2006
33bProvider typeCritical Access Hospital
28Total paid$626K
24GClaims13,215
24DCodes billed36
24AFirst – last monthJan 2018 – Mar 2024
Compared with peers
Next to other Critical Access Hospital providers in Nebraska
Rank by total paid#22 of 53
Median peer was paid$593K
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,489 | $60K | |
| 2019 | 1,195 | $37K | |
| 2020 | 1,522 | $77K | |
| 2021 | 3,441 | $188K | |
| 2022 | 4,632 | $222K | |
| 2023 | 801 | $30K | |
| 2024incomplete | 135 | $12K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 15% | 731 | 673 | $92K |
| 80053 | Comprehensive metabolic panel | 12% | 1,731 | 1,485 | $75K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 11% | 739 | 706 | $71K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.2% | 337 | 289 | $58K |
| 87428 | 9.0% | 789 | 757 | $56K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.8% | 2,018 | 1,672 | $55K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.8% | 561 | 500 | $24K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.3% | 101 | 92 | $21K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.2% | 700 | 360 | $20K |
| 81001 | 2.9% | 1,052 | 935 | $18K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.7% | 436 | 366 | $17K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.4% | 57 | 46 | $15K |
24 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.2% | 277 | $14K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.8% | 252 | $11K |
| 36415 | Collection of venous blood by venipuncture | 1.4% | 1,006 | $9K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.3% | 54 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.3% | 194 | $8K |
| J3490 | Unclassified drugs | 1.3% | 569 | $8K |
| 87807 | 1.2% | 148 | $7K | |
| 85018 | 1.0% | 383 | $6K | |
| 81025 | <1% | 211 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 150 | $5K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 37 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 76 | $3K |
| 80061 | Lipid panel | <1% | 71 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 27 | $2K |
| 87420 | <1% | 12 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 41 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 12 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 61 | $1K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 16 | $1K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 290 | $962.62 |
| 83655 | <1% | 13 | $866.32 | |
| 71045 | Radiologic examination, chest; single view | <1% | 14 | $837.20 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 34 | $772.30 |
| 81003 | <1% | 15 | $353.28 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGAMBLE, LAURA (CEO)
| Provider | Location | Paid |
|---|---|---|
| Pender Community Hospital District | Pender, NE | $2.44M |
| Pender Community Hospital District | Emerson, NE | $141K |
| Pender Community Hospital District | Pender, NE | $805.86 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.